Bank of America Increases Teladoc Health (NYSE:TDOC) Price Target to $11.50

Teladoc Health (NYSE:TDOC) had its price objective increased by equities research analysts at Bank of America from $10.50 to $11.50 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the health services provider’s stock. Bank of America‘s target price points to a potential downside of 11.37% from the company’s current price.

TDOC has been the subject of several other reports. Piper Sandler restated an “overweight” rating and set a $13.00 target price (up from $11.00) on shares of Teladoc Health in a research note on Wednesday, December 4th. TD Cowen cut their target price on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research note on Thursday, October 31st. Oppenheimer cut their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Royal Bank of Canada upped their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Finally, Barclays upped their target price on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Fourteen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, Teladoc Health presently has a consensus rating of “Hold” and a consensus price target of $11.97.

Teladoc Health Trading Up 8.4 %

Shares of TDOC stock opened at $12.98 on Thursday. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The stock has a market cap of $2.23 billion, a P/E ratio of -2.25 and a beta of 1.05. The stock has a 50 day simple moving average of $10.05 and a 200 day simple moving average of $9.14. Teladoc Health has a 1 year low of $6.76 and a 1 year high of $21.74.

Insider Activity at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares in the company, valued at $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.95% of the stock is currently owned by company insiders.

Institutional Trading of Teladoc Health

Institutional investors have recently bought and sold shares of the company. Whipplewood Advisors LLC bought a new stake in Teladoc Health during the fourth quarter valued at $29,000. Versant Capital Management Inc boosted its position in Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 2,441 shares during the last quarter. Lindbrook Capital LLC boosted its position in Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock valued at $33,000 after acquiring an additional 1,612 shares during the last quarter. Blue Trust Inc. boosted its position in Teladoc Health by 84.5% during the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after acquiring an additional 1,854 shares during the last quarter. Finally, Signaturefd LLC boosted its position in Teladoc Health by 162.7% during the third quarter. Signaturefd LLC now owns 7,535 shares of the health services provider’s stock valued at $69,000 after acquiring an additional 4,667 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.